Minerva Neurosciences Reports Fiscal 2020 Fourth Quarter and Year End Financial Results and Business Updates Phase 3 open-label extension completed on schedule in patients with negative symptoms of schizophrenia and data will be available in H1 2021 Minerva’s royalty interest in seltorexant acquired by...

Minerva Neurosciences to Report Fiscal 2020 Fourth Quarter and Year End Financial Results and Business Updates on March 8, 2021 WALTHAM, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...

Gibson Energy Announces 2020 Fourth Quarter and Year-End Results and Announces a Dividend Increase All financial figures are in Canadian dollars unless otherwise noted CALGARY, Alberta, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Gibson Energy Inc. announced today its financial and operating results for...